Lege Artis Medicinae

[TRANSMYOCARDIAL LASER REVASCULARIZATION. FACTS AND QUESTIONS]

SZÉKELY László

OCTOBER 20, 2001

Lege Artis Medicinae - 2001;11(10)

[Transmyocardial laser revascularization (TMLR) is a relatively new technique for the treatment of patients with angina refractory to other medical interventions, such as CABG or PTCA. The laser drills channels through the myocardial wall into the cavity of the ventricle. While the mechanism of action is still debated, clinical data show incentive results suggesting favorable outcome for patients. In the article, the published clinical and experimental data relevant to theoretical mechanisms and clinical results are reviewed.]

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Congress of the Hungarian Society on Thrombosis and Haemostasis Alsópáhok, September 2001]

KISS Róbert Gábor

Lege Artis Medicinae

[ACE Inhibitor for Everyone?]

CZURIGA István

Lege Artis Medicinae

[Epidemiology and Pathogenesis of Inflammatory Bowel Diseases]

KARLINGER Kinga, GYÖRKE Tamás, MAKÓ Ernő, MESTER Ádám, TARJÁN Zsolt

Lege Artis Medicinae

[TEMS]

MATOS Lajos

Lege Artis Medicinae

[The 2nd Congress of the Cardiovascular and Interventional Society, Hungary October 2001, Győr]

LÁZÁR István

All articles in the issue

Related contents

Lege Artis Medicinae

[ACE-INHIBITORS IN THE SECONDARY PREVENTION OF CORONARY ARTERY DISEASE]

SÁRSZEGI Zsolt

[The beneficial effects of angiotensin-converting enzyme inhibitors on biochemical and vascular markers have been proven by many experimental studies. Reduction of the angiotensin-II level has a positive effect on oxidative stress, lipid peroxidation, apoptosis, inflammatory and prothrombotic processes. Two large multicentric trials, EUROPA and HOPE, showed that perindopril and ramipril significantly reduce mortality and the risk of both fatal and non-fatal cardiovascular events in patients with atherosclerosis, thereby making them the base drugs of secondary prevention of coronary artery disease.]

Lege Artis Medicinae

[Heart surgery among octogenerians - fiction or reality?]

SZÉKELY László, GYÖRGY Margit, JUHÁSZ Boglárka, SZABÓ J. Zoltán, SZUDI László, PAULOVICH Erzsébet, LONKAY Eszter, HORKAY Ferenc

[OBJECTIVE - Aging of the society results in important demographic changes in cardiac surgical practice. Controversy exists as to whether heart surgery in elderly patients improves their life expectancy and the severe functional restraint caused by their heart diseases. PATIENTS AND METHODS - We discuss a retrospective study of octogenarian patients who underwent cardiac surgical procedures in our institutions between 01.01.2000. and 30.06.2006. The mean age of the 105 participants was 81.5 years (80-87). 67% (70) of patients had coronary artery disease (CAD). 31% (33) of the patients had aortic valve stenosis (AVR), of whom 16 had isolated AVR and 17 had AVR combined with CAD. One patient had surgery because of mitral valve insufficiency (MVR) only, and one was treated for combined AVR and MVR. The average surgical euroscore was 9.7 (5-18) and the predictive mortalities were 18%. 9.5% of the procedures were acute, 42.9% were urgent and 47.6% were chronic surgeries. RESULTS - The average operating time was 149±23 min, duration of the aortic cross clamp was 65±11 min. OPCAB procedures were performed in 82.9% of patients treated for CAD. In the postoperative period, the occurrence of renal failure was 2.9%, blood transfusions were needed in 37.4% of patients, and neurological deficits occurred in 2.9% of patients. The incidence of perioperative myocardial infarction was 5.6%. The rate of early mortality was 4.8%, the rate of late (>30 days) mortality was 14.3%. At the last follow-up examination, 67 (79%) of the surviving 85 patients were free of cardiac symptoms, physically active and able to take care of themselves. 14 patients (17%) needed some help and only 4 patients (5%) were unable of taking care of themselves. CONCLUSIONS - The mortality of cardiac diseases can be reduced by cardiac surgeries in octagenerians. Improvement of cardiac symptoms improves the patients’ functional status and their quality of life can be similar to that of healthy people of the same age.]

LAM Extra for General Practicioners

[EFFECT OF BETA BLOCKERS IN HYPERTENSION, ISCHAEMIC HEART DISEASE, HEART FAILURE AND METABOLIC SYNDROME]

BENCZÚR Béla

[Beta-blockers are among the most widely used drugs for the treatment of cardiovascular diseases. In the mid-90’s, these drugs were recommended as first-line therapies of hypertension. With the introduction of new drugs, the list of first-choice drugs has been extended. The results of recently published major hypertension trials, which compared conventional agents (beta blockers and/or diuretics) with newer agents (angiotensin converting enzyme inhibitors, Caantagonists, angiotensin receptor blockers), raised concerns regarding the role of beta blockers in cardiovascular primary prevention. Subsequently, a metaanalysis of 13 trials has shown that compared with other drug types, beta-blocker therapy is less beneficial in patients with hypertension who do not have heart disease. Nevertheless, in cardiovascular indications other than hypertension (acute myocardial infarction, heart failure and arrhythmias), betablockers retain their dominant position.]

Lege Artis Medicinae

[Effect of beta blockers in hypertension, ischaemic heart disease, heart failure and metabolic syndrome]

BENCZÚR Béla

[Beta-blockers are among the most widely used drugs for the treatment of cardiovascular diseases. In the mid-90’s, these drugs were recommended as first-line therapies of hypertension. With the introduction of new drugs, the list of first-choice drugs has been extended. The results of recently published major hypertension trials, which compared conventional agents (beta blockers and/or diuretics) with newer agents (angiotensin converting enzyme inhibitors, Caantagonists, angiotensin receptor blockers), raised concerns regarding the role of beta blockers in cardiovascular primary prevention. Subsequently, a metaanalysis of 13 trials has shown that compared with other drug types, beta-blocker therapy is less beneficial in patients with hypertension who do not have heart disease. Nevertheless, in cardiovascular indications other than hypertension (acute myocardial infarction, heart failure and arrhythmias), betablockers retain their dominant position.]

Lege Artis Medicinae

[Percutaneous coronary intervention in ischaemic heart disease]

VOITH László

[In ischaemic heart disease, if the medically treated patient’s anginal complaints and/or ischaemic symptoms are persistent, coronary angiography, and according to its results, coronary intervention (surgery or dilatation) may become necessary. The intervention is required in critical stenosis (>70% diameter) of the main vessels, the emergency depends on the clinical situation. Basic method of coronary angioplasty is the balloon dilatation, other tools (stent, rotablator, laser wire, atherectomy device, etc.) are also available. Periprocedural anticoagulant (heparin) and platelet aggregation inhibitor (aspirin, ticlopidine, GP IIb/III/a receptor blocker) treatment is required, the latter after the procedure as well. After stent implantation the lumen of the vessel is bigger and the incidence of major adverse cardiac events (acute myocardial infarction, repeated intervention, fatal outcome) is diminished. Decrease of serum lipid level improves the outcome of coronary angioplasty. It is applicable successfully for multiple lesions, occluded vessels, stable and unstable angina, in the early phase of myocardial infarction, in patients who underwent coronary surgery, and in old age too. Risk factors of the intervention are: tortuous vessel, significant calcification, stenosis in angle or ostium, luminal thrombus, urgent intervention, old age, female gender, congestive heart failure, unstable condition and acute myocardial infarction. When indicating the intervention, besides the probable results, it is necessary to consider the possibility of complications (myocardial infarction, malignant rhythm disorders, acute heart failure, bleeding, etc.). In left main stem stenosis, 3 vessel disease and in the case of 1 functioning coronary artery surgery would be preferable. With the present facilities the ratio of urgent surgical intervention as well as the mortality is below 1%.]